Lavipharm Sa (0KDJ)
LSE
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current 0KDJ market cap is 35.25M. The company's latest EPS is EUR 0.0111 and P/E is 18.92.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 33.59M | 37.64M | 39.72M | 46.01M | 64.13M |
| Operating Income | 4.86M | 2.54M | 1.22M | 2.39M | 3.65M |
| Net Income | 5.33M | 2.17M | 1.72M | 834k | 1.87M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 49.42M | 50.64M | 52.74M | 114.17M | 114.79M |
| Total Liabilities | 63.79M | 62.91M | 62.68M | 73.86M | 72.02M |
| Total Equity | -14.37M | -12.27M | -9.94M | 40.31M | 42.77M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 2.89M | 2.85M | 3.82M | 3.35M | 284k |
| Investing | -2.41M | -1.47M | -1.88M | -35.59M | -3.46M |
| Financing | -595k | -1.18M | -2.23M | 48.85M | -6.63M |
| Market Cap | 35.25M |
| Price to Earnings Ratio | 18.92 |
| Price to Sales Ratio | 0.55 |
| Price to Cash Ratio | 4.18 |
| Price to Book Ratio | 0.82 |
| Dividend Yield | - |
| Shares Outstanding | 167.87M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 0.21 |
| 52 Week Low | 0.21 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Lavipharm Sa |
| Address |
12, agias marinas street athens, attica 19002 |
| Website | https://www.lavipharm.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
